EFFECTS OF IVABRADINE AND ATENOLOL ON THE PARAMETERS OF CENTRAL AND PERIPHERAL PULSE WAVE CONTOURS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
- Authors: Shavarov A.1, Kiyakbaev G.1, Ezhova L.1, Kobalava Z.1
-
Affiliations:
- Issue: Vol 24, No 5 (2013)
- Pages: 51-54
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115690
- ID: 115690
Cite item
Open Access
Access granted
Abstract
The trial including 40 patients (mean age 63 years) with angina on exertion and postinfarct cardiosclerosis compared the effects of ivabradine and atenolol on central blood pressure and the characteristics of a reflected wave. By comparatively reducing heart rate, atenolol and ivabradine were found to multidirectionally alter cardiac output duration and subendocardial viability ratio.
Keywords
Full Text
References
- Chirinos J., Zambrano J., Chakko S. et al. Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease // Am. J. Cardiol. - 2005; 96: 645-8.
- Jankowski P. Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease // Am. J. Cardiol. - 2006; 97: 590-1.
- Mitchell G., Arnold J., Dunlap M. et al. Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: The CHARM Program // Eur. J. Heart Fail. - 2006; 8: 191-7.
- Wilkinson I., McEniery C., Cockcroft J. Atenolol and cardiovascular risk: an issue close to the heart // Lancet. - 2006; 367: 627-9.
- Westerhof N., Sipkema P., van den Bos G. et al. Forward and backward waves in the arterial system // Cardiovasc. Res. - 1972; 6: 648-56.
- Westerhof N., O’Rourke M. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy // J. Hypertens. - 1995; 13: 943-52.
- Laskey W., Kussmaul W. Arterial wave reflection in heart failure // Circulation. -1987; 75: 711-22.
- Chiu Y., Arand P., Carroll J. Power-afterload relation in the failing human ventricle // Circ. Res. - 1992; 70: 530-5.
- Mulder P., Thuillez C., Camm J. et al. Heart rate slowing for myocardial dysfunction/heart failure: rationale and preclinical studies. Heart rate slowing by If current inhibition // Adv. Cardiol. - 2006; 43: 97-105.
- Van Bortel L., Struijker-Boudier H., Safar M. Pulse pressure, arterial stiffness, and drug treatment of hypertension // Hypertension. - 2001; 38: 14-21.
- Law M., Morris J., Wald N. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiological studies // BMJ. - 2009; 338: 1665-83.
- Williams B. Central aortic pressure and clinical outcomes // J. Hypertens. -2009; 27: 1123-25.
- Акчурин Р.С., Васюк Ю.А., Карпов Ю.А. и др. Национальные рекомендации по диагностике и лечению стабильной стенокардии // Кардиоваск. тер. и профилакт. - 2008; 7 (6) Приложение 4: 1-42.
- Williams B., Lacy P.S., Thom S.M. et al. The CAFE Investigators, CAFE Steering Committee and Writing Committee, Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study // Circulation. - 2006; 113: 1213-25.
Supplementary files
